Clinical Trial Update: Telmisartan in Respiratory Failure Due to COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating telmisartan for respiratory failure in COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Adult
• Respiratory Insufficiency

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Abraham Edgar Gracia-Ramos | Conditions: COVID-19, Respiratory Insufficiency | Phase 2 | Status: COMPLETED